Description: Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Home Page: www.edwards.com
One Edwards Way
Irvine,
CA
92614
United States
Phone:
949 250 2500
Officers
| Name | Title |
|---|---|
| Mr. Bernard J. Zovighian | CEO & Director |
| Mr. Scott B. Ullem | Corporate VP & CFO |
| Mr. Donald E. Bobo Jr. | Corporate Vice President of Strategy & Corporate Development |
| Mr. Larry L. Wood | Corporate VP and Group President of TAVR & Surgical Structural Heart |
| Mr. Andrew M. Dahl | Principal Accounting Officer, Senior VP & Corporate Controller |
| Dr. Todd J. Brinton FACC, M.D. | Corporate VP of Advanced Technology & Chief Scientific Officer |
| Mr. Mark Wilterding | Vice President of Investor Relations |
| Mr. Arnold A. Pinkston J.D. | Corporate VP & General Counsel |
| Mr. Dirksen J. Lehman | Corporate Vice President of Public Affairs |
| Ms. Christine Z. McCauley | Corporate Vice President of Human Resources |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 29.7619 |
|---|---|
| Trailing PE: | 27.8041 |
| Price-to-Book MRQ: | 4.4553 |
| Price-to-Sales TTM: | 6.4353 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 19800 |